Detalhe da pesquisa
1.
A 4-weekly course of rituximab is safe and improves tumor control for patients with minimal residual disease persisting 3 months after autologous hematopoietic stem-cell transplantation: results of a prospective multicenter phase II study in patients with follicular lymphoma.
Ann Oncol
; 23(10): 2687-2695, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22767588
2.
A phase I/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancer.
Br J Cancer
; 103(8): 1154-62, 2010 Oct 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-20808314
3.
Atacicept in relapsed/refractory multiple myeloma or active Waldenström's macroglobulinemia: a phase I study.
Br J Cancer
; 101(7): 1051-8, 2009 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-19789533
4.
Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myeloma.
Oncogene
; 25(54): 7180-91, 2006 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-16732320
5.
Low doses of GM-CSF (molgramostim) and G-CSF (filgrastim) after cyclophosphamide (4 g/m2) enhance the peripheral blood progenitor cell harvest: results of two randomized studies including 120 patients.
Bone Marrow Transplant
; 38(4): 275-84, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16883311
6.
Phenotypic and functional analysis of 1,25-dihydroxyvitamin D3 receptor mediated modulation of the human myeloma cell line RPMI 8226.
Cancer Res
; 48(5): 1213-6, 1988 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-2830017
7.
Treatment of patients with metastatic renal carcinoma with a combination of subcutaneous interleukin-2 and interferon alfa with or without fluorouracil. Groupe Français d'Immunothérapie, Fédération Nationale des Centres de Lutte Contre le Cancer.
J Clin Oncol
; 18(24): 4009-15, 2000 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-11118461
8.
Cytokines in metastatic renal cell carcinoma: is it useful to switch to interleukin-2 or interferon after failure of a first treatment? Groupe Français d'Immunothérape.
J Clin Oncol
; 17(7): 2039-43, 1999 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-10561255
9.
Doxorubicin-containing regimen with or without interferon alfa-2b for advanced follicular lymphomas: final analysis of survival and toxicity in the Groupe d'Etude des Lymphomes Folliculaires 86 Trial.
J Clin Oncol
; 16(7): 2332-8, 1998 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-9667247
10.
Efficacy and safety of oral fludarabine phosphate in previously untreated patients with chronic lymphocytic leukemia.
J Clin Oncol
; 22(7): 1260-7, 2004 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15051774
11.
Optimizing the use of anti-interleukin-6 monoclonal antibody with dexamethasone and 140 mg/m2 of melphalan in multiple myeloma: results of a pilot study including biological aspects.
Bone Marrow Transplant
; 36(9): 771-9, 2005 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16113665
12.
Extensive characterization of dendritic cells generated in serum-free conditions: regulation of soluble antigen uptake, apoptotic tumor cell phagocytosis, chemotaxis and T cell activation during maturation in vitro.
Leukemia
; 14(12): 2182-92, 2000 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-11187909
13.
Immunotherapy by non-myeloablative allogeneic stem cell transplantation in multiple myeloma: results of a pilot study as salvage therapy after autologous transplantation.
Leukemia
; 15(4): 642-6, 2001 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-11368368
14.
Agonist anti-gp130 transducer monoclonal antibodies are human myeloma cell survival and growth factors.
Leukemia
; 14(1): 188-97, 2000 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-10637495
15.
Intensive sequential chemotherapy (ISC 95) with growth factors and blood stem cell support in high-intermediate and high-risk (IPI 2 and IPI 3) aggressive non-Hodgkin's lymphoma: an oligocentric report on 42 patients.
Leukemia
; 13(6): 950-6, 1999 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-10360385
16.
Pneumocystis carinii infection of bone marrow in patients with malignant lymphoma and acquired immunodeficiency syndrome. Original report of three cases.
Arch Intern Med
; 150(2): 450-2, 1990 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-2302020
17.
A ciliary neurotrophic factor-sensitive human myeloma cell line.
Exp Hematol
; 24(10): 1195-200, 1996 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-8765494
18.
Interleukin-10 induces interleukin-11 responsiveness in human myeloma cell lines.
FEBS Lett
; 377(3): 515-8, 1995 Dec 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-8549788
19.
Pilot study of neoadjuvant ifosfamide, cisplatin, and etoposide in locally advanced non-small cell lung cancer.
Eur J Cancer
; 26(7): 798-801, 1990.
Artigo
em Inglês
| MEDLINE | ID: mdl-2171600
20.
Large scale and clinical grade purification of syndecan-1+ malignant plasma cells.
J Immunol Methods
; 205(1): 73-9, 1997 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-9236917